Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stressed and Inflamed, Can GSK3 Be Blamed?
Richard S. Jope, Yuyan Cheng, Jeffrey A. Lowell, et al.
Trends in Biochemical Sciences (2016) Vol. 42, Iss. 3, pp. 180-192
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Eléonore Beurel, Marisa Toups, Charles B. Nemeroff
Neuron (2020) Vol. 107, Iss. 2, pp. 234-256
Open Access | Times Cited: 1398
Microglia in Retinal Degeneration
Khalid Rashid, Isha Akhtar-Schaefer, Thomas Langmann
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 272
Parkinson's disease, aging and adult neurogenesis: Wnt/β‐catenin signalling as the key to unlock the mystery of endogenous brain repair
Bianca Marchetti, Cataldo Tirolo, Francesca L’Episcopo, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 141
Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases
Li Wang, Jiajia Li, Li‐jun Di
Medicinal Research Reviews (2021) Vol. 42, Iss. 2, pp. 946-982
Open Access | Times Cited: 120
FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice
Qingzhi Wang, Jing Yuan, Zhanyang Yu, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 6, pp. 4702-4717
Open Access | Times Cited: 140
GSK3: A Kinase Balancing Promotion and Resolution of Inflammation
Leonie Hoffmeister, Mareike Diekmann, Korbinian Brand, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 820-820
Open Access | Times Cited: 108
Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression
Eva M. Medina‐Rodríguez, Jeffrey A. Lowell, Ryan J. Worthen, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 89
Lithium and Therapeutic Targeting of GSK-3
Melinda Snitow, Rahul S. Bhansali, Peter S. Klein
Cells (2021) Vol. 10, Iss. 2, pp. 255-255
Open Access | Times Cited: 85
Inflammation‐driven brain and gut barrier dysfunction in stress and mood disorders
Ellen Doney, Alice Cadoret, Laurence Dion‐Albert, et al.
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2851-2894
Open Access | Times Cited: 85
An expanding GSK3 network: implications for aging research
Dylan C. Souder, Rozalyn M. Anderson
GeroScience (2019) Vol. 41, Iss. 4, pp. 369-382
Open Access | Times Cited: 78
Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Xiaolei Liu, Anurag Verma, Gustavo Garcia, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 42
Open Access | Times Cited: 72
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy
Thanigaimalai Pillaiyar, Stefan Laufer
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 955-982
Closed Access | Times Cited: 60
Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration
Qiuzhi Zhou, Shihong Li, Mengzhu Li, et al.
EBioMedicine (2022) Vol. 78, pp. 103970-103970
Open Access | Times Cited: 50
miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways
Hailun Jiang, Jianghong Liu, Shuilong Guo, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 539-557
Open Access | Times Cited: 46
GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 40
Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression
Maria Ly, Gary Yu, Ali Mian, et al.
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 10, pp. 853-866
Open Access | Times Cited: 36
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Analı́a Bortolozzi, Giovanna Fico, Michael Berk, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 323-357
Open Access | Times Cited: 8
Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats
Ryan T. McCallum, Rachel-Karson Thériault, Joshua D. Manduca, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
A partnership with the proteasome; the destructive nature of GSK3
Holly Robertson, John D. Hayes, Calum Sutherland
Biochemical Pharmacology (2017) Vol. 147, pp. 77-92
Open Access | Times Cited: 83
Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Erwin Lemche
Current Genomics (2018) Vol. 19, Iss. 7, pp. 522-602
Open Access | Times Cited: 73
Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression
Yushan Jiang, Ying Liu, Ming‐Qing Gao, et al.
Food & Function (2019) Vol. 11, Iss. 1, pp. 378-391
Closed Access | Times Cited: 73
Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models
Fiona Kerr, Ivana Bjedov, Oyinkan Sofola-Adesakin
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 71
Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets
Ana Catarina Pereira, Joana Oliveira, Sónia Silva, et al.
Pharmacological Research (2020) Vol. 163, pp. 105325-105325
Closed Access | Times Cited: 63
Cellular mechanisms and molecular signaling pathways in stress-induced anxiety, depression, and blood–brain barrier inflammation and leakage
Menizibeya O. Welcome
Inflammopharmacology (2020) Vol. 28, Iss. 3, pp. 643-665
Closed Access | Times Cited: 56
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease
Santosh R. D’Mello
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5911-5911
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top